Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
Clinical trial NCT05149898 · COMPLETED
Trial details
- NCT number
- NCT05149898
- Sponsor
- Harmony Biosciences Management, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2022-11-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.